PharmaCielo Ltd. (PCLO.V)
CAD 0.07
(-7.14%)
CAD 0.07
(-7.14%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -16.29 Million CAD | -1.62% |
| 2022 | -16.03 Million CAD | 40.42% |
| 2021 | -26.91 Million CAD | 39.18% |
| 2020 | -44.26 Million CAD | -27.84% |
| 2019 | -34.62 Million CAD | -23877.6% |
| 2018 | -144.39 Thousand CAD | -803.49% |
| 2017 | -15.98 Thousand CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -2.57 Million CAD | -6.41% |
| 2024 Q1 | -2.42 Million CAD | 62.15% |
| 2023 Q4 | -6.39 Million CAD | -131.59% |
| 2023 Q2 | -3.58 Million CAD | -0.91% |
| 2023 FY | -16.29 Million CAD | -1.62% |
| 2023 Q3 | -2.76 Million CAD | 22.99% |
| 2023 Q1 | -3.55 Million CAD | 16.34% |
| 2022 Q2 | -3.7 Million CAD | -31.93% |
| 2022 Q4 | -4.24 Million CAD | 21.03% |
| 2022 FY | -16.03 Million CAD | 40.42% |
| 2022 Q1 | -2.8 Million CAD | 31.7% |
| 2022 Q3 | -5.37 Million CAD | -45.09% |
| 2021 Q1 | -6.54 Million CAD | 72.29% |
| 2021 FY | -26.91 Million CAD | 39.18% |
| 2021 Q4 | -4.11 Million CAD | 53.0% |
| 2021 Q3 | -8.75 Million CAD | -21.13% |
| 2021 Q2 | -7.22 Million CAD | -10.43% |
| 2020 Q4 | -23.6 Million CAD | -286.23% |
| 2020 Q3 | -6.11 Million CAD | 20.83% |
| 2020 Q1 | -6.85 Million CAD | 44.79% |
| 2020 Q2 | -7.71 Million CAD | -12.55% |
| 2020 FY | -44.26 Million CAD | -27.84% |
| 2019 Q1 | -7.73 Million CAD | -56595.57% |
| 2019 FY | -34.62 Million CAD | -23877.6% |
| 2019 Q4 | -12.42 Million CAD | -225.22% |
| 2019 Q3 | -3.81 Million CAD | -0.06% |
| 2019 Q2 | -3.81 Million CAD | 50.67% |
| 2018 Q3 | -38.15 Thousand CAD | -18.98% |
| 2018 FY | -144.39 Thousand CAD | -803.49% |
| 2018 Q1 | -61.66 Thousand CAD | -392.91% |
| 2018 Q2 | -32.06 Thousand CAD | 48.0% |
| 2018 Q4 | -13.64 Thousand CAD | 64.22% |
| 2017 FY | -15.98 Thousand CAD | 0.0% |
| 2017 Q4 | -12.51 Thousand CAD | 21.72% |
| 2017 Q3 | -15.98 Thousand CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | -2.96 Million CAD | -449.719% |
| CanadaBis Capital Inc. | 4.44 Million CAD | 466.693% |
| Decibel Cannabis Company Inc. | -1.77 Million CAD | -820.77% |
| Delivra Health Brands Inc. | 876 Thousand CAD | 1960.461% |
| Entourage Health Corp. | -46.16 Million CAD | 64.699% |
| Lifeist Wellness Inc. | -14.12 Million CAD | -15.376% |
| Cannara Biotech Inc. | 6.94 Million CAD | 334.653% |
| Medicure Inc. | -922 Thousand CAD | -1667.639% |
| Rubicon Organics Inc. | -1.82 Million CAD | -793.738% |
| BioSyent Inc. | 6.46 Million CAD | 352.28% |
| Voyageur Pharmaceuticals Ltd. | -1.39 Million CAD | -1064.558% |